Kevin S Harrod

15PUBLICATIONS
64CO-AUTHORS
Innate immunityMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Predictive and prognostic markersMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 26, 2026
Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural Infection.

|Apr 10, 2026
Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infection.

Davide Botta, Michael D Schultz, Aaron Silva-Sanchez

|Jan 26, 2026
Multispecies transcriptomics reveals influenza A virus modulation of Streptococcus pneumoniae EF3030 infection in human lung epithelium and murine lung.

Adonis D'Mello, Erin Y Earnhardt, Jessica R Lane

|Nov 24, 2025
Mucosal delivery of influenza antigens using a replication deficient adenovirus supports broadly reactive antibody responses and heterologous viral immunity in the respiratory tract of animals.

Michael D Schultz, Davide Botta, Aaron Silva-Sanchez

|Jul 28, 2025
Endoplasmic Reticulum Stress Disrupts the Airway Epithelium and Reduces Host Defense during Influenza A Virus Infection.

Erin Y Earnhardt, Jennifer L Tipper, Mohamed A Hanafy

|Jul 09, 2024
ACE-2 Blockade & TMPRSS2 Inhibition Mitigate SARS-CoV-2 Severity Following Cigarette Smoke Exposure in Airway Epithelial Cells In Vitro.

Shah S Hussain, Emily Falk Libby, Jacelyn E Peabody Lever

Pageof 3

Frequent Collaborators

5 joint publications

Davide Botta

5 joint publications

Michael D Schultz

4 joint publications

Rodney G King

4 joint publications

Frances E Lund